Effects of e-cigarette metal exposure on brain health
Neurotoxic and neurodegenerative risks from chronic exposure to metal mixtures in e-cigarette aerosol
This study looks at how using e-cigarettes with different power settings might affect brain health by causing harmful metal buildup, which could lead to problems with thinking and movement, and it's aimed at helping people understand the risks of long-term e-cigarette use.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11101461 on NIH RePORTER |
What this research studies
This research investigates how chronic exposure to metal mixtures in e-cigarette aerosol affects brain health, particularly focusing on neurotoxic effects and cognitive deficits. The study examines the relationship between the operating power of e-cigarettes and the accumulation of metals in the brain, as well as the resulting neurotoxicity. By using animal models, the researchers aim to understand how different power settings impact metal deposition and associated motor and cognitive impairments over time.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who regularly use e-cigarettes and may be experiencing cognitive or motor function issues.
Not a fit: Patients who do not use e-cigarettes or have no neurological symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and prevention of neurodegenerative disorders linked to e-cigarette use.
How similar studies have performed: Previous research has indicated potential neurotoxic effects from e-cigarette use, suggesting that this study builds on established findings rather than exploring entirely novel territory.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Re, Diane Berengere — Columbia University Health Sciences
- Study coordinator: Re, Diane Berengere
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.